The synthesis of 191Pt labelled JM216, an orally active platinum anti-tumour agent

scientific article published on 01 April 1997

The synthesis of 191Pt labelled JM216, an orally active platinum anti-tumour agent is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0969-8043(96)00267-9
P698PubMed publication ID9106988

P2093author name stringC A McAuliffe
H L Sharma
B A Murrer
C F Bernard
P I Bates
P2860cites workSynthesis and antitumor activity of ammine/amine platinum(II) and (IV) complexesQ36773967
Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerQ39452307
In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum(IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobuQ51608886
Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant diseasQ51609240
Microscale syntheses of anti-tumour platinum compounds labelled with 191PtQ69892557
Carboxylation of Kinetically Inert Platinum(IV) Hydroxy Complexes. An Entr.acte.ee into Orally Active Platinum(IV) Antitumor AgentsQ82203246
P433issue4
P921main subjectsatraplatinQ2226212
P304page(s)469-476
P577publication date1997-04-01
P1433published inApplied Radiation and IsotopesQ541448
P1476titleThe synthesis of 191Pt labelled JM216, an orally active platinum anti-tumour agent
P478volume48

Search more.